Population
Patients with neoplastic pericardial disease
Design
Review
Authors
Loading...
Supports tailoring neoplastic pericardial therapy to malignancy type; leaves open prospective trials for confirmation.
This review highlights that therapeutic strategies for neoplastic pericardial disease should be tailored to the underlying malignancy, such as intrapericardial chemotherapy for lung cancer.
Lestuzzi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: